Page last updated: 2024-11-07

idoxuridine and Myelodysplastic Syndromes

idoxuridine has been researched along with Myelodysplastic Syndromes in 4 studies

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research Excerpts

ExcerptRelevanceReference
"Sixty-eight patients with myelodysplastic syndromes (MDS) received sequential infusions of iodo- and/or bromodeoxyuridine for cell kinetic analysis."7.69Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine. ( Alston, D; Alvi, S; Borok, RZ; Broady-Robinson, L; Cartlidge, J; Chopra, HK; Dar, SE; Gezer, S; Gregory, SA; Hernandez, B; Hines, C; Loew, J; Mundle, SD; Parcharidou, A; Raza, A; Rifkin, S; Robin, E; Shah, R; Shetty, VT; Showel, J; Showel, M; Span, L; Venugopal, P, 1997)
"Sixty-eight patients with myelodysplastic syndromes (MDS) received sequential infusions of iodo- and/or bromodeoxyuridine for cell kinetic analysis."3.69Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine. ( Alston, D; Alvi, S; Borok, RZ; Broady-Robinson, L; Cartlidge, J; Chopra, HK; Dar, SE; Gezer, S; Gregory, SA; Hernandez, B; Hines, C; Loew, J; Mundle, SD; Parcharidou, A; Raza, A; Rifkin, S; Robin, E; Shah, R; Shetty, VT; Showel, J; Showel, M; Span, L; Venugopal, P, 1997)
"Examination of the proliferative characteristics of myeloblasts was undertaken in situ in bone marrow (BM) biopsies of patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following sequential infusions of iodo- (IUdR) and bromodeoxyuridine (BrdU)."3.68In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies. ( Akhtar, S; Bohkari, SA; Chughtai, S; Masterson, M; Mehdi, SA; Miller, MA; Raza, A; Sheikh, Y; Umerani, A; Yousuf, N, 1992)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mundle, S1
Iftikhar, A1
Shetty, V1
Dameron, S1
Wright-Quinones, V1
Marcus, B1
Loew, J2
Gregory, S1
Raza, A3
Alvi, S1
Broady-Robinson, L1
Showel, M1
Cartlidge, J1
Mundle, SD1
Shetty, VT1
Borok, RZ1
Dar, SE1
Chopra, HK1
Span, L1
Parcharidou, A1
Hines, C1
Gezer, S1
Venugopal, P1
Showel, J1
Alston, D1
Hernandez, B1
Rifkin, S1
Robin, E1
Shah, R1
Gregory, SA1
Yousuf, N1
Bohkari, SA1
Sheikh, Y1
Akhtar, S1
Chughtai, S1
Umerani, A1
Mehdi, SA1
Miller, MA1
Masterson, M1
Naito, K1
Yamada, K1

Other Studies

4 other studies available for idoxuridine and Myelodysplastic Syndromes

ArticleYear
Novel in situ double labeling for simultaneous detection of proliferation and apoptosis.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 1994, Volume: 42, Issue:12

    Topics: Acute Disease; Apoptosis; Bone Marrow; Bromodeoxyuridine; Cell Division; DNA; DNA, Neoplasm; Hematop

1994
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine.
    Experimental hematology, 1997, Volume: 25, Issue:6

    Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle; DNA; Humans; Idoxuridine; Myelodysplastic Syndromes

1997
In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies.
    Leukemia research, 1992, Volume: 16, Issue:3

    Topics: Biopsy; Biopsy, Needle; Bone Marrow; Bromodeoxyuridine; Cell Cycle; Humans; Idoxuridine; Leukemia, M

1992
[Serum deoxythymidine kinase in hematological malignancy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:12

    Topics: Acute Disease; Adult; Chronic Disease; Humans; Idoxuridine; Leukemia; Myelodysplastic Syndromes; Thy

1988